These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

806 related articles for article (PubMed ID: 30296054)

  • 1. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery.
    Kurbegovic S; Juhl K; Chen H; Qu C; Ding B; Leth JM; Drzewiecki KT; Kjaer A; Cheng Z
    Bioconjug Chem; 2018 Nov; 29(11):3833-3840. PubMed ID: 30296054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
    Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
    Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
    Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
    Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor α-targeted dual-modal nanoprobe.
    Shi X; Xu P; Cao C; Cheng Z; Tian J; Hu Z
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4325-4337. PubMed ID: 35838757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
    Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
    Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105.
    Juhl K; Christensen A; Persson M; Ploug M; Kjaer A
    PLoS One; 2016; 11(2):e0147428. PubMed ID: 26828431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
    Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
    Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
    Tang C; Du Y; Liang Q; Cheng Z; Tian J
    Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.
    Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H
    J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma.
    Baart VM; van der Horst G; Deken MM; Bhairosingh SS; Schomann T; Sier VQ; van der Mark MH; Iamele L; de Jonge H; Resnati M; Mazar AP; Pelger RCM; van der Pluijm G; Kuppen PJK; Vahrmeijer AL; Sier CFM
    Eur J Cancer; 2021 Mar; 146():11-20. PubMed ID: 33561783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-infrared II fluorescence-guided glioblastoma surgery targeting monocarboxylate transporter 4 combined with photothermal therapy.
    Zhao H; Li C; Shi X; Zhang J; Jia X; Hu Z; Gao Y; Tian J
    EBioMedicine; 2024 Aug; 106():105243. PubMed ID: 39004066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
    Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A
    J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Small-Molecule NIR-II Fluorescence Imaging of Osteosarcoma and Lung Metastasis.
    Zhou H; Yi W; Li A; Wang B; Ding Q; Xue L; Zeng X; Feng Y; Li Q; Wang T; Li Y; Cheng X; Tang L; Deng Z; Wu M; Xiao Y; Hong X
    Adv Healthc Mater; 2020 Jan; 9(1):e1901224. PubMed ID: 31793757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models.
    Pu T; Liu Y; Pei Y; Peng J; Wang Z; Du M; Liu Q; Zhong F; Zhang M; Li F; Xu C; Zhang X
    ACS Appl Mater Interfaces; 2023 Jul; 15(27):32226-32239. PubMed ID: 37385963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection.
    Li L; Du Y; Chen X; Tian J
    Mol Imaging Biol; 2018 Dec; 20(6):930-939. PubMed ID: 29651576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of Red Blood Cell-Based Multimodal Theranostic Probes for Second Near-Infrared Window Fluorescence Imaging-Guided Tumor Surgery and Photodynamic Therapy.
    Wang P; Wang X; Luo Q; Li Y; Lin X; Fan L; Zhang Y; Liu J; Liu X
    Theranostics; 2019; 9(2):369-380. PubMed ID: 30809280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
    Yang L; Sajja HK; Cao Z; Qian W; Bender L; Marcus AI; Lipowska M; Wood WC; Wang YA
    Theranostics; 2013; 4(1):106-18. PubMed ID: 24396518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved positron emission tomography imaging of glioblastoma cancer using novel
    Loft MD; Sun Y; Liu C; Christensen C; Huang D; Kjaer A; Cheng Z
    Amino Acids; 2017 Jun; 49(6):1089-1100. PubMed ID: 28316028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
    Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM
    Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.
    Boonstra MC; van Driel PB; van Willigen DM; Stammes MA; Prevoo HA; Tummers QR; Mazar AP; Beekman FJ; Kuppen PJ; van de Velde CJ; Löwik CW; Frangioni JV; van Leeuwen FW; Sier CF; Vahrmeijer AL
    Oncotarget; 2015 Jun; 6(16):14260-73. PubMed ID: 25895028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.